BP000060-C125: Recombinant Human β-defensin 1 (BD-1) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000063-C126: Recombinant Human β Defensin-4 (BD-4) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000060-CYT-044: Recombinant Mouse Beta-defensin 1 (BD-1) Protein
Source: E. coli-derived.
The specific activity is measured by its ability to chemoattract CD34+ dendritic cells using a concentration range of 0.1-1.0 ug/ml, corresponding to a specific activity of 1,000-10,000 units/mg.
Purity: > 97.0% by HPLC and SDS-PAGE.BP000060-CYT-062: Recombinant Rat Beta-defensin 1 (BD-1) Protein
Source: E. coli-derived.
The specific activity is measured by its ability to chemoattract CD34+ dendritic cells using a concentration range of 0.1-1.0 ug/ml.
Purity: > 95.0% by HPLC and SDS-PAGE.BP000060-CYT-564: Recombinant Human Beta
BP000062-CYT-036: Recombinant Mouse Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
The specific ativity is measured by its antimicrobial activity against E. coli. The ED50 for this effect is typically 4-20 ug/ml, corresponding to a specific activity of 50,000-250,000 units/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000062-CYT-063: Recombinant Rat Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
The specific ativity is measured by its antimicrobial activity against E. coli. The ED50 for this effect is typically 4-20 ug/ml, corresponding to a specific activity of 50,000-250,000 units/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000062-CYT-461: Recombinant Human Beta Defensin-3 (BD 3) Protein
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000063-CYT-066: Recombinant Rat Beta Defensin-4 (BD-4) Protein
Source: E. coli-derived.
The specific activity is measured by its antimicrobial activity against E. coli. The ED50 for this effect is typically 5-50 ug/ml.
Purity: > 97% by SDS-PAGE and RP-HPLC.